ProAir Digihaler in COPD Disease Management: A Real World Study to Assess ProAir Digihaler Inhalation Parameters Thresholds and Their Use to Identify Deterioration in Clinical Practice
Latest Information Update: 28 Jun 2022
Price :
$35 *
At a glance
- Drugs Salbutamol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 23 Jun 2022 Status changed from active, no longer recruiting to completed.
- 18 Apr 2022 Planned End Date changed from 31 Mar 2022 to 30 Jun 2022.
- 18 Apr 2022 Planned primary completion date changed from 31 Mar 2022 to 30 Jun 2022.